Call for Abstract

6th Euro
Virology Congress and Expo, will be organized around the theme “An Insight on Advances in Virology and Infectious Diseases”

Euro Virology 2016 is comprised of 14 tracks and 90 sessions designed to offer comprehensive sessions that address current issues in Euro Virology 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

The global animal healthcare market was esteemed at USD 27,861.2 million in 2013 and is expected to grow at a CAGR of 7.1% from 2014 to 2019, to achieve an expected estimation of USD 41,929.1 million in 2019.

Veterinary virology is the study of viruses in animals. It is an important branch of veterinary medicine. An emerging virus is a term applied to a newly discovered virus, one that is increasing in incidence or with the potential to increase in incidence. Zoonotic diseases/infections are those which can be naturally transmissible from vertebrate animals to humans. Prion disease represents a group of conditions that affect the nervous system in humans and animals.

  • Track 1-1Pestiviruses
  • Track 1-2Arteriviruses
  • Track 1-3Hantavirus
  • Track 1-4Toroviruses
  • Track 1-5Avian influenza
  • Track 1-6Circoviruses
  • Track 1-7Flaviviruses
  • Track 1-8Paramyxoviruses

The worldwide business sector for drug discovery technologies and products reached $38.4 billion in 2011. It is expected to expand to $41.4 billion in 2012 and to $79.0 billion in 2017, a compound annual growth rate (CAGR) of 13.8% somewhere around 2012 and 2017. Another report by visiongain, an independent media company based in London, predicts that the world market for drug discovery outsourcing will reach $16.6 billion in 2015.

 Drug-drug interactions occur when a drug interacts, or interferes, with another drug modify the way one or both of the drugs act in the body, or cause unexpected side effects. The drugs involved can be prescription medications, over-the-counter medicines and even vitamins and natural products.

  • Track 2-1Bioinformatics in Drug discovery
  • Track 2-2Toxicology
  • Track 2-3Clinical Studies
  • Track 2-4Pre-Clinical Methods
  • Track 2-5Computer aided Drug Designing
  • Track 2-6Phenotypic Screening

The global stem cell therapy market over the forecast period of 2015 to 2020. The business is ready to grow at a CAGR of 39.5% from 2015 to 2020, to achieve $330million by 2020.

Stem cell therapy is the utilization of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem cell therapy, but some therapies derived from umbilical cord blood are also in use. Clinical or medical virology is a branch of medicine which consists in isolating and/or in characterizing one or several viruses responsible for some human pathologies by various different immediate or circuitous systems.

  • Track 3-1Approaches by life cycle stage
  • Track 3-2Gene delivery
  • Track 3-3Protein manufacturing
  • Track 3-4Human monoclonal antibody isolation
  • Track 3-5High-throughput sequencing
  • Track 3-6Structure-based vaccine design

The vaccine technology market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%.

Major factors driving growth of vaccine technology market include rising prevalence of diseases, increasing government initiatives for expanding immunization across the globe, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans.

  • Track 4-1Stem cell therapy for viral infections: promises and challenges
  • Track 4-2Strain identification assays and rapid diagnostic testing for viral infections
  • Track 4-3New strategies to combat flu viruses
  • Track 4-4Latest Developments in the Prophylactic and the Therapeutic Segment

As indicated by the U.S. Community for Disease Control and Prevention (CDC), Respiratory syncytial infection (RSV) is the basic reason for bronchiolitis or pneumonia in the youngsters under one year of age in the United States. Every year 75,000 to 125,000 kids are hospitalized because of RSV diseases.

An alphavirus belongs to the group IV Togaviridae family of viruses as per the arrangement of grouping taking into account viral genome organization presented by David Baltimore. Filoviruses belong to a virus family called Filoviridae and can cause severe hemorrhagic fever in humans and nonhuman primates. Picornaviruses are non-wrapped, positive-stranded RNA viruses with an icosahedral capsid. West Nile virus is a mosquito-borne zoonotic arbovirus belonging to the genus Flavivirus in the family Flaviviridae.

  • Track 5-1Viral Genomics and Proteomics
  • Track 5-2Cellular Factors Affecting Viral Replication and Pathogenicity
  • Track 5-3Viral Tropism and Transmission
  • Track 5-4Viral Replication Cycle

Due to the widespread infection of HCV and demand for these enhanced treatments, multiple estimates forecast the global market for HCV treatment will reach $20 billion yearly before the decade's get over.

Hepatitis is a medical condition defined by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. Hepatitis A is an intense irresistible infection of the liver caused by the hepatitis A virus. Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects the liver. It can cause both intense and chronic infections. HCV is spread primarily by blood-to-blood contact connected with intravenous drug use, inadequately cleaned therapeutic gear, and transfusions.

  • Track 6-1HIV Associated Diseases
  • Track 6-2Swine flu outbreak,Prevention & Treatment
  • Track 6-3Corona Viruses
  • Track 6-4Severe acute respiratory syndrome
  • Track 6-5Polio virus
  • Track 6-6Oncovirus.
  • Track 6-7Virus Receptors & Viral Entry
  • Track 6-8Herpes & Pox Viruses
  • Track 6-9Filoviruses-Ebola virus & Westnile Viruses
  • Track 6-10Viral meningitis
  • Track 6-11Influenza Viruses
  • Track 6-12HIV and retroviral transmission and prevention
  • Track 6-13HPV & Other Sexually Transmitted Diseases

Due to the widespread infection of HCV and demand for these enhanced treatments, multiple estimates forecast the global market for HCV treatment will reach $20 billion yearly before the decade's get over.

Hepatitis is a medical condition defined by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. Hepatitis A is an intense irresistible infection of the liver caused by the hepatitis A virus. Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects the liver. It can cause both intense and chronic infections. HCV is spread primarily by blood-to-blood contact connected with intravenous drug use, inadequately cleaned therapeutic gear, and transfusions.

  • Track 7-1Hepatitis A
  • Track 7-2Hepatitis B
  • Track 7-3Hepatitis C
  • Track 7-4Hepatitis D
  • Track 7-5Hepatitis E
  • Track 7-6Epidemiology hepatitis

 

The global infectious immunology market is forecast to reach $8.8 billion by 2017, growing at a compound annual growth rate (CAGR) of 6% during the period 2010-2017. The hepatitis infections fragment developed at 7% and was esteemed at $2 billion in 2010.

Cell signaling is part of a complex system of communication that administers basic cellular activities and coordinates cell activities. A Neutralizing antibody is an antibody which safeguards a cell from an antigen or infectious body by inhibiting or neutralizing any effect it has biologically. Cell-mediated immunity is an immune response that does not involve antibodies, but rather involves the activation of phagocytes, antigen-specific cytotoxic T-lymphocytes, and the release of various cytokines in response to an antigen.

  • Track 8-1Applications of viral vectors
  • Track 8-2Advances in antiviral vaccine development
  • Track 8-3Types of Vaccines
  • Track 8-4DIVA Vaccines
  • Track 8-5Vectors in Gene Therapy

The agricultural inoculants market, in terms of value is anticipated to reach $398.56 million by 2019, at a CAGR of around 9.5% from 2014.

The epidemiology of plant virus diseases concerns the cyclical development of virus diseases within plant populations in time and space. Tobacco mosaic virus (TMV) is a positive-sense single stranded RNA virus that infects a wide range of plants, especially tobacco and other members of the family Solanaceae. Mycology is the branch of science which deals with the study of fungi, including their genetic and biochemical properties, their taxonomy and their use to humans as a source for tinder, medicine, wine and entheogens, as well as their dangers, such as poisoning or infection.

  • Track 9-1Plant virus epidemiology, ecology and evolution
  • Track 9-2Transmission of plant viruses
  • Track 9-3Translation of plant viral proteins
  • Track 9-4Tobacco Mosaic Virus
  • Track 9-5Bymovirus
  • Track 9-6Geminivirus
  • Track 9-7Phycodnaviridae
  • Track 9-8Tobamovirus
  • Track 9-9Mycology

Clinical Trial Management System (CTMS) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019", states that the global clinical trial management systems market, which was worth US$844 million in 2013, will grow at a CAGR of 14% between 2013 and 2019 to acquire net worth of an estimated US$1,848.5 million by 2019.

Vector-borne diseases are infections transmitted by the bite of infected arthropod species, such as mosquitoes, ticks, sandflies, blackflies,etc. A blood-borne disease  is one that can be spread through contamination by blood and other body fluids. RNA silencing controls gene expression to regulate development, genome stability and anxiety incited reactions. In plants, RNA silencing is also recognized as a major immune system targeted against plant viruses.

  • Track 10-1Diagnostic methods in virology
  • Track 10-2Mechanism of Viral entry into the nervous system
  • Track 10-3Vector and Blood borne Diseases & Molecular Diagnosis of CNS Viral Infections
  • Track 10-4Aging and Metabolic Syndromes of Neurologic Disorders by Viruses
  • Track 10-5Tools used for diagnosing neuroviral infections

The Americas commanded the most sizably voluminous share 42% of the Ecumenical Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.

Viral infections is one of the major cause of human and animal disease. Virus genomes are very small and they are incredibly diverse and subject to rapid genetic change. Viruses have their own ways of transmission. The mobility of animals increases the mechanisms of viral transmittance that have evolved, whereas plants remain immobile and thus viruses must rely on environmental factors to be transmitted between hosts.

  • Track 11-1Hand-foot-and-mouth (HFM) disease
  • Track 11-2Herpangina
  • Track 11-3Myocarditis
  • Track 11-4Aseptic meningitis
  • Track 11-5Pleurodynia

The Americas commanded the largest share 42% of the Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.

DNA immunization is a novel method used to efficiently fortify humoral and cellular immune responses to protein antigens. Viral vaccines contain either inactivated viruses or constricted viruses .Inactive viral vaccines contain a virus, which have lost their ability to replicate and in order for it to bring about a response it contains more antigen than live immunizations. Allergy immunotherapy is a clinically documented efficacious treatment, which may considerably reduce the patient’s allergic symptoms and the need for traditional, symptom-relieving medication. Antiviral drugs are a class of medication utilized particularly for treating viral contaminations.

  • Track 12-1 Oncolytic virotherapy
  • Track 12-2Viral immunotherapy
  • Track 12-3 DNA Immunization
  • Track 12-4Antigen presenting cell-targeted therapy
  • Track 12-5Antiviral drugs and adjuvants

The global Cancer/Tumor Profiling Market was esteemed at $13.30 billion in 2012. At the end of 2013, the market is assessed to be $14.99 billion and is poised to reach around $35 billion by 2018, developing at a CAGR of 18.50% from 2013 to 2018.

Viral gastroenteritis is an inflammation of the stomach and intestines caused by one of any number of viruses. It is also known as the stomach flu. Hepatocellular carcinoma is the most common type of liver cancer. Most instances of HCC are secondary to either a viral hepatitis infection or cirrhosis. Simian virus 40,a polyomavirus that is found in both monkeys and humans. It was named for the impact it created on infected green monkey cells, which developed an unusual number of vacuoles.

  • Track 13-1Viral Gastroenteritis
  • Track 13-2SV40 and Polyomavirus
  • Track 13-3Retroviruses
  • Track 13-4Clinical immunology
  • Track 13-5Cancer immunology
  • Track 13-6Mammalian tumour Viruses

The global infectious immunology market is forecast to reach $8.8 billion by 2017, growing at a compound annual growth rate (CAGR) of 6% during the period 2010-2017. The hepatitis infections fragment developed at 7% and was esteemed at $2 billion in 2010.

Cell signaling is part of a complex system of communication that administers basic cellular activities and coordinates cell activities. A Neutralizing antibody is an antibody which safeguards a cell from an antigen or infectious body by inhibiting or neutralizing any effect it has biologically. Cell-mediated immunity is an immune response that does not involve antibodies, but rather involves the activation of phagocytes, antigen-specific cytotoxic T-lymphocytes, and the release of various cytokines in response to an antigen.

  • Track 14-1Chemotherapy
  • Track 14-2Radiotherapy
  • Track 14-3Cellular immunotherapy
  • Track 14-4Cancer immunotherapy
  • Track 14-5Antibody therapy
  • Track 14-6Cytokine therapy
  • Track 14-7Immune system stimulation
  • Track 14-8Acquired resistance